Valuation: Olympus Corporation

Market Cap 1,825B 11.34B 9.91B 9.1B 8.49B 16.09B 1,080B 16.36B 110B 42.46B 530B 42.58B 41.66B P/E 2027 *
18.9x
P/E 2028 * 15.7x
Enterprise Value 1,895B 11.78B 10.29B 9.45B 8.81B 16.7B 1,121B 16.99B 114B 44.09B 550B 44.22B 43.25B EV / Sales 2027 *
1.78x
EV / Sales 2028 * 1.7x
Free-Float
94.53%
Yield 2027 *
1.79%
Yield 2028 * 1.88%
1 day+2.91%
1 week+4.99%
Current month+4.06%
1 month-4.54%
3 months+14.06%
6 months-13.10%
Current year-10.91%
1 week 1,636
Extreme 1636
1,780
1 month 1,610
Extreme 1610
1,896.5
Current year 1,302.5
Extreme 1302.5
2,137
1 year 1,302.5
Extreme 1302.5
2,168
3 years 1,302.5
Extreme 1302.5
2,867
5 years 1,302.5
Extreme 1302.5
3,198
10 years 758.75
Extreme 758.75
3,198
Manager TitleAgeSince
Chief Executive Officer 63 31/05/2025
Director of Finance/CFO 59 31/03/2026
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 69 31/03/2023
Director/Board Member 41 31/05/2019
Director/Board Member 63 31/05/2019
Change 5-day change 1-year change 3-year change Capi.($)
+2.91%+4.99%+4.71%-23.55% 11.34B
+1.97%+3.50%+22.37%+0.32% 195B
+5.87%+6.59%-21.20%+24.59% 151B
+2.17%+2.44%-2.26%-17.53% 140B
+4.83%+2.13%-56.44%-16.55% 67.09B
+2.59%+5.18%+22.53%+0.04% 54.34B
-0.27%+2.02%-25.61%-31.12% 44.64B
-2.02%-3.56%+8.31%+8.68% 36.91B
+0.31%+0.64%+7.78%+42.30% 37.24B
+1.09%+0.96%-13.87%-19.29% 29.82B
Average +1.38%+2.47%-5.37%-3.21% 76.69B
Weighted average by Cap. +1.53%+3.38%-3.43%-0.17%

Financials

2027 *2028 *
Net sales 1,065B 6.62B 5.78B 5.31B 4.95B 9.39B 630B 9.55B 63.96B 24.79B 309B 24.86B 24.32B 1,107B 6.88B 6.01B 5.52B 5.15B 9.76B 655B 9.92B 66.44B 25.75B 321B 25.82B 25.26B
Net income 98.47B 612M 535M 491M 458M 868M 58.26B 883M 5.91B 2.29B 28.58B 2.3B 2.25B 118B 731M 638M 586M 547M 1.04B 69.56B 1.05B 7.06B 2.74B 34.12B 2.74B 2.68B
Net Debt 69.9B 434M 380M 349M 325M 616M 41.36B 627M 4.2B 1.63B 20.29B 1.63B 1.6B 51.9B 323M 282M 259M 241M 458M 30.71B 465M 3.12B 1.21B 15.06B 1.21B 1.18B
Logo Olympus Corporation
Olympus Corp is a Japan-based company mainly engaged in the manufacture and sale of endoscopes, therapeutic equipment, scientific and other products. The Company operates through three business segments. The Endoscope segment provides gastrointestinal endoscopes, surgical endoscopes, and medical services. The Therapeutic Equipment segment provides gastrointestinal treatment instruments, urology products, respiratory products, energy devices, otolaryngology products and gynecology products. The Others segment provides biomaterials and orthopedic instruments. The Company is also engaged in the business activities, including holding companies and financial investments related to each business.
Employees
28,138
Date Price Change Volume
03/07/26 JP¥1,768.00 +2.91% 3,647,100
02/07/26 JP¥1,718.00 +4.37% 3,453,700
01/07/26 JP¥1,646.00 -3.12% 2,996,800
30/06/26 JP¥1,699.00 -1.45% 4,405,700
29/06/26 JP¥1,724.00 +2.38% 5,222,500
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
1,718.00JPY
Average target price
1,913.08JPY
Spread / Average Target
+11.35%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 7733 Stock